Free Trial

Concentrix (CNXC) to Release Earnings on Thursday

Concentrix logo with Business Services background

Key Points

  • Concentrix (NASDAQ: CNXC) is projected to report its Q3 2025 earnings on September 25th, with analysts expecting earnings of $2.88 per share and revenue of $2.4586 billion.
  • The company's last earnings report showed an EPS of $2.70, missing estimates, while revenue rose 1.5% year-over-year to $2.42 billion.
  • Concentrix recently declared a quarterly dividend of $0.3328 per share, representing an annualized yield of 2.4%.
  • Five stocks we like better than Concentrix.

Concentrix (NASDAQ:CNXC - Get Free Report) will likely be issuing its Q3 2025 results after the market closes on Thursday, September 25th. Analysts expect the company to announce earnings of $2.88 per share and revenue of $2.4586 billion for the quarter. Concentrix has set its FY 2025 guidance at 11.530-11.760 EPS. Q3 2025 guidance at 2.800-2.910 EPS.Parties are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, September 25, 2025 at 5:00 PM ET.

Concentrix (NASDAQ:CNXC - Get Free Report) last posted its quarterly earnings results on Thursday, June 26th. The company reported $2.70 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.06). Concentrix had a return on equity of 16.31% and a net margin of 2.54%.The company had revenue of $2.42 billion during the quarter, compared to analysts' expectations of $2.38 billion. During the same quarter in the previous year, the company earned $2.69 EPS. The business's quarterly revenue was up 1.5% on a year-over-year basis.

Concentrix Stock Down 0.2%

CNXC traded down $0.13 during trading on Friday, hitting $56.97. 1,412,391 shares of the company's stock traded hands, compared to its average volume of 659,577. The company's 50 day simple moving average is $52.77 and its two-hundred day simple moving average is $52.46. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.14. Concentrix has a 12-month low of $36.28 and a 12-month high of $66.00. The stock has a market capitalization of $3.59 billion, a price-to-earnings ratio of 15.65, a PEG ratio of 0.76 and a beta of 0.53.

Concentrix Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 5th. Shareholders of record on Friday, July 25th were paid a dividend of $0.3328 per share. This represents a $1.33 annualized dividend and a yield of 2.3%. The ex-dividend date was Friday, July 25th. Concentrix's dividend payout ratio (DPR) is currently 36.54%.

Insider Transactions at Concentrix

In other Concentrix news, EVP Cormac J. Twomey sold 500 shares of the firm's stock in a transaction dated Wednesday, July 30th. The shares were sold at an average price of $57.91, for a total value of $28,955.00. Following the completion of the sale, the executive vice president owned 37,130 shares of the company's stock, valued at $2,150,198.30. This trade represents a 1.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.20% of the stock is currently owned by insiders.

Institutional Trading of Concentrix

Institutional investors and hedge funds have recently modified their holdings of the stock. Geneos Wealth Management Inc. increased its holdings in Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock valued at $34,000 after buying an additional 522 shares during the period. Osaic Holdings Inc. increased its holdings in Concentrix by 13.4% during the second quarter. Osaic Holdings Inc. now owns 2,222 shares of the company's stock valued at $118,000 after buying an additional 263 shares during the period. Federated Hermes Inc. increased its holdings in Concentrix by 81.6% during the second quarter. Federated Hermes Inc. now owns 4,294 shares of the company's stock valued at $227,000 after buying an additional 1,930 shares during the period. Creative Planning purchased a new position in Concentrix in the second quarter worth $251,000. Finally, Corient Private Wealth LLC purchased a new position in Concentrix in the second quarter worth $292,000. Institutional investors own 90.34% of the company's stock.

Wall Street Analysts Forecast Growth

CNXC has been the topic of several research analyst reports. Robert W. Baird increased their price target on Concentrix from $72.00 to $75.00 and gave the company an "outperform" rating in a report on Thursday. Canaccord Genuity Group reissued a "buy" rating and set a $80.00 price target on shares of Concentrix in a report on Monday, June 30th. Barrington Research reaffirmed an "outperform" rating and issued a $54.00 target price on shares of Concentrix in a report on Tuesday, June 24th. Wall Street Zen cut Concentrix from a "buy" rating to a "hold" rating in a report on Saturday, June 21st. Finally, Bank of America cut their price target on Concentrix from $65.00 to $61.00 and set a "neutral" rating for the company in a research note on Friday, June 27th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $67.50.

Read Our Latest Stock Report on Concentrix

Concentrix Company Profile

(Get Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

See Also

Earnings History for Concentrix (NASDAQ:CNXC)

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.